Abh Healthcare Ltd vs Suven Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of ABH Healthcare Ltd is ₹ 41.5 as of 23 Oct 15:30 . The P/E Ratio of ABH Healthcare Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of ABH Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Suven Life Sciences Ltd changed from ₹ 896.07 crore on March 2021 to ₹ 3503 crore on March 2026 . This represents a CAGR of 25.51% over 6 years The revenue of ABH Healthcare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Suven Life Sciences Ltd for the Jun '26 is ₹ 11.09 crore as compare to the Mar '26 revenue of ₹ 8.3 crore. This represent the growth of 33.61% The ebitda of ABH Healthcare Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Suven Life Sciences Ltd for the Jun '26 is ₹ -124 crore as compare to the Mar '26 ebitda of ₹ -43.86 crore. This represent the growth of 184.95% The net profit of ABH Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Suven Life Sciences Ltd changed from ₹ -28.04 crore to ₹ -127 crore over 9 quarters. This represents a CAGR of 96.11% The Dividend Payout of ABH Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Suven Life Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About ABH Healthcare Ltd

ABH Healthcare Limited was originally incorporated as a private limited company in the name and style of 'ABH Healthcare Private Limited' vide certificate of incorporation dated March 2, 2021 issued by Registrar of Companies, Central Registration Centre.
Further, Company acquired the sole Proprietorship Concern of Dr. Kamal Baghi, our Promoter in the name 'Anil Baghi Hospital' via Business Transfer Agreement dated March 16, 2022.
Subsequently, it was converted from a private Company to a public Company and the name was changed to 'ABH Healthcare Limited', and a fresh Certificate of incorporation dated November 15, 2024 was issued by the Registrar of Companies, Chandigarh. The Company operate hospital under the 'Anil Baghi Hospital' brand, honoring the sacrifice of late Shri Anil Baghi.
Located in Ferozepur, Punjab, hospital has a capacity of 150 beds.

About Suven Life Sciences Ltd

Suven Life Sciences Limited was initially established as 'Suven Pharmaceuticals Limited' in March, 1989 and changed to the present name in September 2003.
The Company is a clinical-stage biopharma company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
Company focus on the discovery and clinical development of innovative medicines to address the unmet medical needs in central nervous system (CNS) disorders. Promoted by Venkateswarlu Jasti, Company began the business in 1989 as specialty chemicals provider. In March 1995, the Company came out with a public issue of 9.8 lac equity shares at a premium of Rs 40 aggregating Rs 4.9 cr to part-finance the company's project for the manufacture of bulk drugs and drug intermediates and meet long-term working capital requirements totalling to Rs 6.

FAQs for the comparison of null and Suven Life Sciences Ltd

Which company has a larger market capitalization, ABH Healthcare Ltd or Suven Life Sciences Ltd?

Market cap of ABH Healthcare Ltd is 47 Cr while Market cap of Suven Life Sciences Ltd is 7,397 Cr

What are the key factors driving the stock performance of ABH Healthcare Ltd and Suven Life Sciences Ltd?

The stock performance of ABH Healthcare Ltd and Suven Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ABH Healthcare Ltd and Suven Life Sciences Ltd?

As of October 25, 2026, the ABH Healthcare Ltd stock price is INR ₹41.5. On the other hand, Suven Life Sciences Ltd stock price is INR ₹261.8.

How do dividend payouts of ABH Healthcare Ltd and Suven Life Sciences Ltd compare?

To compare the dividend payouts of ABH Healthcare Ltd and Suven Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.